BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10966795)

  • 1. Membrane-induced conformational change during the activation of HIV-1 gp41.
    Kliger Y; Peisajovich SG; Blumenthal R; Shai Y
    J Mol Biol; 2000 Aug; 301(4):905-14. PubMed ID: 10966795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
    Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
    Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O; Sackett K; Shai Y
    J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein.
    Jelesarov I; Lu M
    J Mol Biol; 2001 Mar; 307(2):637-56. PubMed ID: 11254387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIV gp41 binds to membranes both in the monomeric and trimeric states: consequences for the neuropathology and inhibition of HIV infection.
    Peisajovich SG; Shai Y
    J Mol Biol; 2001 Aug; 311(2):249-54. PubMed ID: 11478858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes.
    Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J
    Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomic structure of the ectodomain from HIV-1 gp41.
    Weissenhorn W; Dessen A; Harrison SC; Skehel JJ; Wiley DC
    Nature; 1997 May; 387(6631):426-30. PubMed ID: 9163431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity.
    Ryu JR; Jin BS; Suh MJ; Yoo YS; Yoon SH; Woo ER; Yu YG
    Biochem Biophys Res Commun; 1999 Nov; 265(3):625-9. PubMed ID: 10600471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
    Wexler-Cohen Y; Sackett K; Shai Y
    Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp41 tertiary structure studied by EPR spectroscopy.
    Rabenstein MD; Shin YK
    Biochemistry; 1996 Nov; 35(44):13922-8. PubMed ID: 8909289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution.
    Yang ZN; Mueser TC; Kaufman J; Stahl SJ; Wingfield PT; Hyde CC
    J Struct Biol; 1999 Jun; 126(2):131-44. PubMed ID: 10388624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional trimerization and lytic activity of HIV-1 gp41 variants containing the membrane-associated segments.
    Dai Z; Tao Y; Liu N; Brenowitz MD; Girvin ME; Lai JR
    Biochemistry; 2015 Mar; 54(8):1589-99. PubMed ID: 25658332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
    Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
    FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.